Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15050426rdf:typepubmed:Citationlld:pubmed
pubmed-article:15050426lifeskim:mentionsumls-concept:C1879327lld:lifeskim
pubmed-article:15050426lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:15050426lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:15050426lifeskim:mentionsumls-concept:C0020885lld:lifeskim
pubmed-article:15050426lifeskim:mentionsumls-concept:C1510470lld:lifeskim
pubmed-article:15050426lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15050426lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15050426lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:15050426pubmed:issue23lld:pubmed
pubmed-article:15050426pubmed:dateCreated2004-3-30lld:pubmed
pubmed-article:15050426pubmed:abstractTextGinger (Zingiber officinale rhizome) is a widespread herbal medicine mainly used for the treatment of gastrointestinal diseases, including dyspepsia, nausea and diarrhoea. In the present study we evaluated the effect of this herbal remedy on the contractions induced by electrical stimulation (EFS) or acetylcholine in the isolated rat ileum. Ginger (0.01-1000 microg/ml) inhibited both EFS- and acetylcholine-evoked contractions, being more potent in inhibiting the contractions induced by EFS. The depressant effect of ginger on EFS-induced contractions was reduced by the vanilloid receptor antagonist capsazepine (10(-5) M), but unaffected by the alpha(2)-adrenergic antagonist yohimbine (10(-7) M), the CB(1) receptor antagonist SR141716A (10(-6) M), the opioid antagonist naloxone (10(-6) M) or by the NO synthase inhibitor L-NAME (3 x 10(-4) M). Zingerone (up to 3 x 10(-4) M), one of the active ingredients of ginger, did not possess inhibitory effects. It is concluded that ginger possesses both prejunctional and postjunctional inhibitory effects on ileal contractility; the prejunctional inhibitory effect of ginger on enteric excitatory transmission could involve a capsazepine-sensible site (possibly vanilloid receptors).lld:pubmed
pubmed-article:15050426pubmed:languageenglld:pubmed
pubmed-article:15050426pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15050426pubmed:citationSubsetIMlld:pubmed
pubmed-article:15050426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15050426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15050426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15050426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15050426pubmed:statusMEDLINElld:pubmed
pubmed-article:15050426pubmed:monthAprlld:pubmed
pubmed-article:15050426pubmed:issn0024-3205lld:pubmed
pubmed-article:15050426pubmed:authorpubmed-author:PintoAldoAlld:pubmed
pubmed-article:15050426pubmed:authorpubmed-author:IzzoAngelo...lld:pubmed
pubmed-article:15050426pubmed:authorpubmed-author:BorrelliFranc...lld:pubmed
pubmed-article:15050426pubmed:authorpubmed-author:CapassoRaffae...lld:pubmed
pubmed-article:15050426pubmed:issnTypePrintlld:pubmed
pubmed-article:15050426pubmed:day23lld:pubmed
pubmed-article:15050426pubmed:volume74lld:pubmed
pubmed-article:15050426pubmed:ownerNLMlld:pubmed
pubmed-article:15050426pubmed:authorsCompleteYlld:pubmed
pubmed-article:15050426pubmed:pagination2889-96lld:pubmed
pubmed-article:15050426pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:meshHeadingpubmed-meshheading:15050426...lld:pubmed
pubmed-article:15050426pubmed:year2004lld:pubmed
pubmed-article:15050426pubmed:articleTitleInhibitory effect of ginger (Zingiber officinale) on rat ileal motility in vitro.lld:pubmed
pubmed-article:15050426pubmed:affiliationDepartment of Experimental Pharmacology, University of Naples Federico II, Via D. Montesano 49, 80131 Naples, Italy.lld:pubmed
pubmed-article:15050426pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15050426pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:15050426pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15050426lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15050426lld:pubmed